Orlucent, Inc. Receives Registered Trademark

Los Gatos, CA, January 19, 2023 – The U.S. Patent and Trademark Office has granted Orlucent® a registered trademark, allowing them to more clearly identify and distinguish their fluorescent molecular imaging test and secure legal protections for the brand. The Orlucent Fluorescent Molecular Imaging System is the first handheld molecular-based imaging system to provide the physician with greater certainty in the clinical assessment of suspicious moles. The in-office system uses a novel fluorescent biotag topically applied to non-invasively detect a biomarker of early tissue changes that occur during a mole’s transition from benign to atypia.